Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

£20m Boost for UK Regenerative Medicine

Published: Thursday, April 11, 2013
Last Updated: Thursday, April 11, 2013
Bookmark and Share
The MRC and British Heart Foundation (BHF) announced £20m of funding to boost the development of regenerative medicine therapies.

The awards will help UK scientists overcome some of the barriers to transforming laboratory discoveries in this emerging field into clinical applications that will address a spectrum of chronic and untreatable medical conditions.

Around £13m will be awarded through the first stage of the UK Regenerative Medicine Platform (UKRMP), which is jointly funded by the MRC, the Biotechnology and Biological Sciences Research Council and Engineering and Physical Sciences Research Council. This will establish three research ‘hubs’ that bring together teams of scientists with skills and expertise in a range of disciplines to tackle the grand challenges in regenerative medicine.

The BHF has pledged a further £7.5 million to fund scientists at three new dedicated research centres, based at prestigious universities across the UK. The three BHF Centres for Regenerative Medicine, funded by the Mending Broken Hearts Appeal, will specialise in looking for new treatments to repair the damage caused by a heart attack.

Regenerative medicine is a relatively new field of science which uses a range of biological tools to repair or replace damaged tissue. This field has the potential to transform medical care by providing treatments for incurable conditions such as heart disease, Parkinson’s disease, blindness and liver failure.

Though there have been many advances in laboratory studies of stem cells and other regenerative approaches, to date relatively few therapies have made it to human trials. This is largely because cell-based therapies are far more complex than traditional small molecule drugs, and require further research and new approaches to make sure they are safe, effective and can be produced in the volumes required to treat large numbers of patients.

The UKRMP hubs will work together, with the BHF centres, to address these issues and develop the tools, technologies and engineering solutions needed to take regenerative therapies into the clinic. The hubs will each focus on a specific theme:

•    Engineering and exploiting the stem cell niche (microenvironment), led by the MRC Centre for Regenerative Medicine at the University of Edinburgh.
•    Safety and efficacy of cell therapies, led by the MRC Centre for Drug Safety Science at the University of Liverpool.
•    Acellular (biomaterial) approaches and targeted drug delivery for tissue regeneration, led by the University of Nottingham.

A further hub looking at the development of high quality, stable stem cell lines and their direction towards specific tissue types to support manufacture for clinical application is expected to be established later in the year. In total, the UKRMP aims to invest £25m by March 2014.

Minister for Universities and Science David Willetts said:

“Regenerative medicine is a hugely promising area of science, which is why it featured in our Strategy for UK Life Sciences and was identified as one of the eight great technologies. This investment will help take excellent basic research through to clinical application, benefitting patients and driving growth.”

Dr Rob Buckle from the MRC, who is Director of the UKRMP, said:

“Today’s investment from the Research Councils and British Heart Foundation will help the UK move closer to realising the full potential of regenerative medicine to transform the lives of patients. By bringing together experts from a broad range of scientific disciplines the hubs will help forge links between academia and industry to drive innovation, promote clinical and commercial development of therapies and help grow a vibrant UK bioindustry in this area.”

Professor Peter Weissberg, Medical Director at the BHF, said:

“We’re excited by the transformational impact these centres could have on science aimed at repairing heart damage. By working with the UK Regenerative Medicine Platform’s hubs, our BHF Centres of Regenerative Medicine will turn groundbreaking research into real benefits for people with heart failure. We have committed to spending £7.5m on these centres over the coming years from our Mending Broken Hearts Appeal, but this depends crucially on continued support from the public. You can help by supporting our Mending Broken Hearts Appeal.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Wednesday, July 22, 2015
‘Mini Bile Ducts’ used to Discover New Drugs that could Prevent Liver Damage
An experimental cystic fibrosis drug has been shown to prevent the disease’s damage to the liver, thanks to a world-first where scientists grew mini bile ducts in the lab.
Tuesday, July 14, 2015
£25m to Kick-Start ‘Industrial Revolution’ in Regenerative Medicine
Applications will include Parkinson’s disease, cardiovascular disease, wound and musculoskeletal repair, eye disorders and deafness.
Wednesday, September 11, 2013
3D Tissue Grown from Stem Cells - New Model System for Brain Development
An international team of researchers has used stem cells to create a 3D structure that mimics early human brain development.
Monday, September 02, 2013
New Type of Blood Stem Cell Could Help Solve Platelet Shortage
Scientists have identified a new type of bone marrow stem cell in mice that is primed to produce large numbers of vital blood-clotting platelets.
Tuesday, August 13, 2013
£93 Million Package of Support Announced for UK’s Health Industries
Innovative business and academic projects will benefit from a new £93.2 million package of support.
Wednesday, July 31, 2013
Scientists Transplant Photoreceptors from Retina Grown ‘in a Dish’
Scientists have carried out the first successful transplant of light-sensitive photoreceptor cells taken from a synthetic retina, grown ‘in a dish’ from embryonic stem cells.
Tuesday, July 23, 2013
Human Brain Research Made Easier by Database
Researchers will be able to access samples from more than 7,000 donated human brains to help study major brain diseases, thanks to a new on-line database, launched by the MRC.
Thursday, March 21, 2013
MRC Delivering on the Life Sciences Strategy, One Year On
The Medical Research Council has made significant progress in implementing the measures outlined in last year’s Strategy for UK Life Sciences, according to a progress update published by the Government.
Tuesday, December 11, 2012
Stem Cells Created from Patient’s Own Blood
Scientists have discovered a patient-friendly and efficient way to make stem cells out of blood, increasing the hope that scientists could one day use stem cells made from patients’ own cells to treat cardiovascular disease.
Tuesday, December 04, 2012
First Randomised Controlled Trial to Show Spinal Cord Regeneration in Dogs
Medical Research Council researchers have shown it is possible to restore co-ordinated limb movement in dogs with severe spinal cord injury (SCI).
Monday, November 19, 2012
International Collaboration Brings Stem Cell Clinical Trials a Step Closer
Funding for two ambitious projects aimed at bringing stem cell treatments to the point of clinical trial has been unveiled by the Medical Research Council (MRC) today.
Friday, October 30, 2009
Setting the Record Straight: Hybrid Embryo Research
The Medical Research Council (MRC) sets the record straight following concerns about the level of investment in hybrid stem cell research, raised on the front page of today’s Independent.
Tuesday, October 06, 2009
MRC welcomes new blueprint for life sciences
A new Blueprint to put innovation at the heart of healthcare delivery in the UK has been launched by Lord Drayson and Lord Darzi at Imperial College London.
Wednesday, July 15, 2009
Virus-free Pluripotency for Human Cells
Scientists have paved the way for stem cells made from skin cells to be safely transplanted into humans – by overcoming one of the main health risks associated with previous techniques.
Monday, March 02, 2009
Scientific News
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Stem Cells Rescue Patients from Mitochondrial Disease
A study led by OHSU researchers has revealed a critical first step in developing a new gene and stem cell regenerative technique for treating patients with mitochondrial disease.
Eco-Friendly Nanobullet to Battle Bacteria
Researchers have developed a method to combat bacteria by engineering nanoscale particles that add the antimicrobial potency of silver to a core of lignin, a ubiquitous substance found in all plant cells.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!